Further research revealed that after parthenolide treatment, in addition to a significant decrease in overall cell viability, the Ki-67 positivity rates of surviving cells also decreased significantly, indicating that the induction of differentiation by parthenolide attenuated the proliferative capacity of glioma cells. This evidence concerns the gene MKI67 and central nervous system cancer.